TP53 and pancreatic intraductal papillary-mucinous neoplasm: KRAS mutations were detected in all PDAC and in 3 of 5 AVC and IPMN; TP53 mutations in 3 of 5 PDAC, 3 of 5 GC and 2 of 5 IPMN, respectively.